Par Drugs and Chemicals Ltd

PAR Share Price

NSE

₹86.640.69% (+0.59)

Health Care

Pharmaceuticals

Smallcap

With a market cap of ₹104 cr, stock is ranked 3,002

Moderate Risk

Stock is 2.89x as volatile as Nifty

PAR Stock Scorecard

Performance

Low

Hasn't fared well - amongst the low performers

Valuation

Avg

Can be considered moderately valued vs the market

Growth

Low

Lagging behind the market in financials growth

Profitability

High

Showing good signs of profitability & efficiency

Entry point

Good

The stock is underpriced and is not in the overbought zone

Red flags

Low

No red flag found

How to use scorecard? Learn more

Health Care

Pharmaceuticals

Smallcap

With a market cap of ₹104 cr, stock is ranked 3,002

Moderate Risk

Stock is 2.89x as volatile as Nifty

PAR Performance & Key Metrics

No LabelNo Label	PB RatioPB Ratio	Dividend YieldDiv. Yield
7.49	1.05	—

Sector PESector PE	Sector PBSector PB	Sector Div YldSctr Div Yld
34.79	5.49	0.61%

PAR Analyst Ratings & Forecast

—

Analyst Ratings data is currently unavailable for this stock

Price Upside

Earnings Growth

Rev. Growth

PAR Company Profile

Par Drugs and Chemicals provides generic drugs. The Company is engaged in the development and manufacturing of Active Pharma Ingredients (APIs) for the domestic market, as well as for exports to international markets

PAR Similar Stocks (Peers)

Compare with peers Compare with peers

PAR Similar Stocks (Peers)

Compare with peers Compare with peers

Sun Pharmaceutical Industries Ltd

SUNPHARMA

PE Ratio

38.60

1Y Return

1.74%

Buy Reco %

94.12

Torrent Pharmaceuticals Ltd

TORNTPHARM

PE Ratio

74.62

1Y Return

32.43%

Buy Reco %

81.48

Lupin Ltd

LUPIN

PE Ratio

31.99

1Y Return

13.48%

Buy Reco %

72.22

Dr Reddy's Laboratories Ltd

DRREDDY

PE Ratio

18.45

1Y Return

10.43%

Buy Reco %

51.61

Cipla Ltd

CIPLA

PE Ratio

18.72

1Y Return

17.65%

Buy Reco %

51.61

Compare with Peers

PAR Forecast

PAR Forecasts

PAR

Income

Balance Sheet

Cash Flow

Financial Year		FY 2017		FY 2018		FY 2019		FY 2020		FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	TTM
Total Revenue	48.81	42.42	46.42	55.94	62.93	75.25	95.99	95.88	103.12	110.81
Raw Materials	19.59	17.94	19.22	22.19	22.09	29.61	41.03	33.32	39.41	88.26
Power & Fuel Cost	8.45	6.94	8.90	10.70	9.82	13.49	17.83	16.40	19.49
Employee Cost	1.84	2.04	3.64	4.11	3.98	4.10	4.89	5.50	5.85
Selling & Administrative Expenses	3.30	2.81	1.97	4.58	5.62	8.22	9.60	10.16	11.63
Operating & Other expenses	7.13	4.67	4.39	4.81	3.23	3.40	4.20	7.44	5.09
EBITDA	8.50	8.02	8.30	9.55	18.19	16.43	18.44	23.06	21.65	22.55
Depreciation/Amortization	2.82	3.14	3.04	2.76	2.82	3.28	3.23	3.44	3.65	3.69
PBIT	5.68	4.88	5.26	6.79	15.37	13.15	15.21	19.62	18.00	18.86
Interest & Other Items	2.50	2.33	1.96	0.79	0.64	0.45	0.13	0.11	0.08	0.10
PBT	3.18	2.55	3.30	6.00	14.73	12.70	15.08	19.51	17.92	18.76
Taxes & Other Items	1.34	1.06	0.78	1.23	3.11	3.49	3.75	5.02	4.57	4.84
Net Income	1.84	1.49	2.52	4.77	11.62	9.21	11.33	14.49	13.35	13.92
EPS	1.70	1.38	1.75	3.16	9.44	7.48	9.21	11.78	10.85	11.31
DPS	0.00	0.00	0.00	1.25	0.00	0.00	0.00	0.00	0.00	0.00
Payout ratio	0.00	0.00	0.00	0.40	0.00	0.00	0.00	0.00	0.00	0.00

PAR Income Statement

Quarter		sep 2023		dec 2023		mar 2024		jun 2024		sep 2024	dec 2024	mar 2025	jun 2025	sep 2025	dec 2025
Total Revenue	25.94	24.23	22.77	22.68	35.67	21.65	23.12	27.88	29.14	30.67
Operating & Other expenses	18.52	18.77	16.73	18.37	23.25	19.95	19.90	22.49	22.59	23.28
EBITDA	7.42	5.46	6.04	4.31	12.42	1.70	3.22	5.39	6.55	7.39
Depreciation/Amortization	0.85	0.87	0.89	0.90	0.91	0.91	0.92	0.90	0.94	0.93
PBIT	6.57	4.59	5.15	3.41	11.51	0.79	2.30	4.49	5.61	6.46
Interest & Other Items	0.03	0.02	0.05	0.02	0.03	0.01	0.02	0.02	0.05	0.01
PBT	6.54	4.57	5.10	3.39	11.48	0.78	2.28	4.47	5.56	6.45
Taxes & Other Items	1.65	1.15	1.39	0.85	2.89	0.19	0.63	1.15	1.42	1.64
Net Income	4.89	3.42	3.71	2.54	8.59	0.59	1.65	3.32	4.14	4.81
EPS	3.97	2.78	3.02	2.06	6.99	0.47	1.34	2.70	3.36	3.90

Financial Year		FY 2016		FY 2017		FY 2018		FY 2019		FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025
Cash from Operating Activities	6.53	9.17	4.32	2.10	7.69	12.09	7.62	13.38	20.25	16.16
Cash from Investing Activities	-0.17	-1.70	-0.60	-0.25	-1.46	0.05	-3.02	-7.34	-5.84	-25.24
Cash from Financing Activities	-5.46	-8.38	-3.67	-1.88	1.11	1.65	-9.55	0.00	0.00	0.00
Net Change in Cash	+0.90	-0.91	+0.05	-0.03	+7.34	+13.79	-4.95	+6.04	+14.41	-9.08
Changes in Working Capital	-0.58	+0.77	-3.32	-4.25	-1.70	-3.93	-8.56	-4.73	-2.37	-4.34
Capital Expenditures	0.15	1.81	0.64	0.34	1.56	5.05	3.20	7.63	6.08	1.23
Free Cash Flow	6.38	7.36	3.68	1.76	6.13	7.04	4.42	5.75	14.17	14.93

PAR Company Updates

FY 2023FY 2023

Annual Report Pending

Investor Presentation

Jun 26PDF

Jun 1PDF

Feb 20PDF

+3 more

FY 2022FY 2022

Annual Report Unavailable

Investor Presentation

May 14PDF

Feb 10PDF

Dec 15PDF

Nov 16PDF

PAR Stock Peers

PAR Past Performance & Peer Comparison

Comparing 3 stocks from
Health CarePharmaceuticals

Valuation

Technical

Forecast

Compare valuation on Screener

Stock	PE RatioPE Ratio	PB RatioPB Ratio	Div. YieldDividend Yield
Par Drugs and Chemicals Ltd	7.81	1.05	—
Sun Pharmaceutical Industries Ltd	38.60	5.82	0.91%
Torrent Pharmaceuticals Ltd	74.62	18.79	0.76%
Lupin Ltd	31.99	6.07	0.52%

PAR Stock Price Comparison

Compare PAR with any stock or ETF

PAR

PAR Holdings

PAR Shareholdings

PAR Promoter Holdings Trend

PAR Institutional Holdings Trend

PAR Shareholding Pattern

PAR Shareholding History

Foreign Institutions

PAR Insider Trades & Bulk Stock Deals

smallcases containing PAR stock

Looks like this stock is not in any smallcase yet.

PAR Events

PAR Dividend Trend

Dividends

Corp. Actions

Announcements

Legal Orders

PAR Dividend Trend

PAR Upcoming Dividends

No upcoming dividends are available

PAR Past Dividends

Cash Dividend

Ex DateEx DateNov 22, 2021

Interim

Interim | Div/Share: ₹1.25

Dividend/Share

₹1.25

Ex DateEx Date

Nov 22, 2021

Cash Dividend

Ex DateEx DateJul 10, 2020

Final

Final | Div/Share: ₹1.25

Dividend/Share

₹1.25

Ex DateEx Date

Jul 10, 2020

Cash Dividend

Ex DateEx DateNov 22, 2019

Interim

Interim | Div/Share: ₹1.25

Dividend/Share

₹1.25

Ex DateEx Date

Nov 22, 2019

No upcoming corporate actions are available

Bonus

Ex DateEx DateApr 27, 2021

1:1 Bonus Issue Equity Shares

1:1 Bonus Issue Equity Shares | Ratio: 1:1

Ratio

1:1

Ex DateEx Date

Apr 27, 2021

No upcoming announcements are available

Copy of Newspaper Publication

Announced OnFeb 11, 2026

Par Drugs And Chemicals Limited has info

Par Drugs And Chemicals Limited has info Download

Link

Download

Announced On

Feb 11, 2026

Updates

Announced OnFeb 10, 2026

Par Drugs And Chemicals Limited has info

Par Drugs And Chemicals Limited has info Download

Link

Download

Announced On

Feb 10, 2026

Outcome of Board Meeting

Announced OnFeb 10, 2026

Par Drugs And Chemicals Limited has info

Par Drugs And Chemicals Limited has info Download

Link

Download

Announced On

Feb 10, 2026

Outcome of Board Meeting

Announced OnFeb 10, 2026

Par Drugs And Chemicals Limited has info

Par Drugs And Chemicals Limited has info Download

Link

Download

Announced On

Feb 10, 2026

Outcome of Board Meeting

Announced OnFeb 10, 2026

Par Drugs And Chemicals Limited has subm

Par Drugs And Chemicals Limited has subm Download

Link

Download

Announced On

Feb 10, 2026

PAR Legal Orders

Hmm, looks like data is unavailable here. Please come back after some time

PAR Stock News & Opinions

Earnings

Par Drugs & Chemicals standalone net profit rises 727.59% in the December 2025 quarter

Net profit of Par Drugs & Chemicals rose 727.59% to Rs 4.80 crore in the quarter ended December 2025 as against Rs 0.58 crore during the previous quarter ended December 2024. Sales rose 37.23% to Rs 29.34 crore in the quarter ended December 2025 as against Rs 21.38 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales29.3421.38 37 OPM %20.626.64 - PBDT7.371.68 339 PBT6.440.77 736 NP4.800.58 728 Powered by Capital Market - Live

1 month agoCapital Market - Live

Corporate

Par Drugs & Chemicals to declare Quarterly Results

Par Drugs & Chemicals will hold a meeting of the Board of Directors of the Company on 10 February 2026.Powered by Capital Market - Live

1 month agoCapital Market - Live

Earnings

Par Drugs & Chemicals standalone net profit declines 51.98% in the September 2025 quarter

Net profit of Par Drugs & Chemicals declined 51.98% to Rs 4.13 crore in the quarter ended September 2025 as against Rs 8.60 crore during the previous quarter ended September 2024. Sales declined 17.31% to Rs 28.66 crore in the quarter ended September 2025 as against Rs 34.66 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales28.6634.66 -17 OPM %21.1432.92 - PBDT6.4912.40 -48 PBT5.5511.49 -52 NP4.138.60 -52 Powered by Capital Market - Live

4 months agoCapital Market - Live

Corporate

Par Drugs & Chemicals to hold board meeting

Par Drugs & Chemicals will hold a meeting of the Board of Directors of the Company on 13 November 2025.Powered by Capital Market - Live

4 months agoCapital Market - Live

Corporate

Par Drugs & Chemicals to hold AGM

Par Drugs & Chemicals announced that the 26th Annual General Meeting(AGM) of the company will be held on 27 September 2025.Powered by Capital Market - Live

6 months agoCapital Market - Live

Corporate

Par Drugs & Chemicals announces board meeting date

Par Drugs & Chemicals will hold a meeting of the Board of Directors of the Company on 29 August 2025.Powered by Capital Market - Live

7 months agoCapital Market - Live

Earnings

Par Drugs & Chemicals standalone net profit rises 31.62% in the June 2025 quarter

Net profit of Par Drugs & Chemicals rose 31.62% to Rs 3.33 crore in the quarter ended June 2025 as against Rs 2.53 crore during the previous quarter ended June 2024. Sales rose 15.21% to Rs 26.05 crore in the quarter ended June 2025 as against Rs 22.61 crore during the previous quarter ended June 2024. ParticularsQuarter EndedJun. 2025Jun. 2024% Var. Sales26.0522.61 15 OPM %13.6718.71 - PBDT5.384.28 26 PBT4.483.38 33 NP3.332.53 32 Powered by Capital Market - Live

7 months agoCapital Market - Live

Corporate

Par Drugs & Chemicals to conduct board meeting

Par Drugs & Chemicals will hold a meeting of the Board of Directors of the Company on 7 August 2025.Powered by Capital Market - Live

7 months agoCapital Market - Live

Earnings

Par Drugs & Chemicals standalone net profit declines 55.65% in the March 2025 quarter

Net profit of Par Drugs & Chemicals declined 55.65% to Rs 1.65 crore in the quarter ended March 2025 as against Rs 3.72 crore during the previous quarter ended March 2024. Sales declined 2.15% to Rs 22.33 crore in the quarter ended March 2025 as against Rs 22.82 crore during the previous quarter ended March 2024. For the full year,net profit declined 7.86% to Rs 13.36 crore in the year ended March 2025 as against Rs 14.50 crore during the previous year ended March 2024. Sales rose 5.57% to Rs 100.97 crore in the year ended March 2025 as against Rs 95.64 crore during the previous year ended March 2024. ParticularsQuarter EndedYear EndedMar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var. Sales22.3322.82 -2 100.9795.64 6 OPM %10.8826.73 -19.3223.87 - PBDT3.206.00 -47 21.5822.96 -6 PBT2.285.11 -55 17.9319.52 -8 NP1.653.72 -56 13.3614.50 -8 Powered by Capital Market - Live

10 months agoCapital Market - Live

Corporate

Par Drugs & Chemicals announces board meeting date

Par Drugs & Chemicals will hold a meeting of the Board of Directors of the Company on 8 May 2025.Powered by Capital Market - Live

10 months agoCapital Market - Live

Frequently asked questions

What is the share price of Par Drugs and Chemicals Ltd (PAR) today?
The share price of PAR as on 25th March 2026 is ₹86.64. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.
What is the return on Par Drugs and Chemicals Ltd (PAR) share?
The past returns of Par Drugs and Chemicals Ltd (PAR) share are
- Past 1 week: -3.72%
- Past 1 month: -8.43%
- Past 3 months: -19.38%
- Past 6 months: -20.13%
- Past 1 year: -9.11%
- Past 3 years: -36.29%
- Past 5 years: 46.90%
What are the peers or stocks similar to Par Drugs and Chemicals Ltd (PAR)?
The peers or stocks similar to Par Drugs and Chemicals Ltd (PAR) include:
What is the market cap of Par Drugs and Chemicals Ltd (PAR) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Par Drugs and Chemicals Ltd (PAR) is ₹104.32 Cr as of 25th March 2026.
What is the 52 week high and low of Par Drugs and Chemicals Ltd (PAR) share?
The 52-week high of Par Drugs and Chemicals Ltd (PAR) is ₹122.43 and the 52-week low is ₹81.01.
What is the PE and PB ratio of Par Drugs and Chemicals Ltd (PAR) stock?
The P/E (price-to-earnings) ratio of Par Drugs and Chemicals Ltd (PAR) is 7.81. The P/B (price-to-book) ratio is 1.05.
Which sector does Par Drugs and Chemicals Ltd (PAR) belong to?
Par Drugs and Chemicals Ltd (PAR) belongs to the Health Care sector & Pharmaceuticals sub-sector.
How to buy Par Drugs and Chemicals Ltd (PAR) shares?
You can directly buy Par Drugs and Chemicals Ltd (PAR) shares on Tickertape. Simply sign up, connect your demat account and place your order.

Stock	VolatilityVolatility	RSI–14DRSI – 14D	Price Mom RankPrice Momentum Rank
Par Drugs and Chemicals Ltd	38.60%	32.70	Pro
Sun Pharmaceutical Industries Ltd	19.88%	51.27
Torrent Pharmaceuticals Ltd	20.88%	37.73
Lupin Ltd	23.71%	48.04

Par Drugs and Chemicals Ltd

PAR Share Price

PAR Stock Scorecard

PAR Performance & Key Metrics

PAR Performance & Key Metrics

PAR Analyst Ratings & Forecast

Price Upside

Earnings Growth

Rev. Growth

PAR Company Profile

PAR Similar Stocks (Peers)

PAR Similar Stocks (Peers)

PAR Forecast

PAR Forecasts

PAR